日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Impact of Minimal Dose Strategy Before Antithyroid Drug Discontinuation on Relapse Risk in Graves' Disease

抗甲状腺药物停用前最小剂量策略对格雷夫斯病复发风险的影响

Miyamura, Keitaro; Ito, Mitsuru; Yamaoka, Hiroyuki; Hisakado, Mako; Nishihara, Eijun; Fukata, Shuji; Nishikawa, Mitsushige; Miyauchi, Akira; Akamizu, Takashi

Interference in thyroid function tests using the electrochemiluminescence immunoassay

使用电化学发光免疫分析法进行甲状腺功能检测的干扰

Imamura, Chisako; Nishihara, Eijun; Fukata, Shuji; Ito, Mitsuru; Nishikawa, Mitsushige; Miyauchi, Akira; Akamizu, Takashi

Ultrasound findings suggestive of microscopic extranodal extension in papillary thyroid carcinoma

超声检查结果提示乳头状甲状腺癌存在微小的结外侵犯

Miyamoto, Noriko; Hirokawa, Mitsuyoshi; Higuchi, Miyoko; Oshita, Maki; Kawakami, Makoto; Yamaoka, Hiroyuki; Fujishima, Makoto; Miyauchi, Akira; Akamizu, Takashi

Correction: Ultrasound findings suggestive of microscopic extranodal extension in papillary thyroid carcinoma

更正:超声检查结果提示乳头状甲状腺癌存在微小的结外侵犯

Miyamoto, Noriko; Hirokawa, Mitsuyoshi; Higuchi, Miyoko; Oshita, Maki; Kawakami, Makoto; Yamaoka, Hiroyuki; Fujishima, Makoto; Miyauchi, Akira; Akamizu, Takashi

Medullary thyroid carcinoma exclusively associated with a homozygous RET V778I pathogenic variant: a case report with review of literature

髓样甲状腺癌仅与纯合RET V778I致病变异相关:病例报告及文献复习

Kihara, Minoru; Miyauchi, Akira; Akamizu, Takashi

A randomised, double-masked, placebo-controlled trial evaluating the efficacy and safety of teprotumumab for active thyroid eye disease in Japanese patients

一项随机、双盲、安慰剂对照试验,旨在评估替普鲁单抗治疗日本活动性甲状腺眼病患者的疗效和安全性

Hiromatsu, Yuji; Ishikawa, Eri; Kozaki, Ai; Takahashi, Yasuhiro; Tanabe, Mika; Hayashi, Ken; Imagawa, Yukihiro; Kaneda, Kazutoyo; Mimura, Masashi; Dai, Xiaoxian; Hayashida, Tomoko; Akamizu, Takashi

Corrigendum to "A randomised, double-masked, placebo-controlled trial evaluating the efficacy and safety of teprotumumab for active thyroid eye disease in Japanese patients" The Lancet Regional Health-Western Pacific, Volume 55 (2025), 101464

更正:“一项评估替普鲁单抗治疗日本活动性甲状腺眼病患者的疗效和安全性的随机、双盲、安慰剂对照试验”,《柳叶刀区域健康-西太平洋》,第55卷(2025年),101464

Hiromatsu, Yuji; Ishikawa, Eri; Kozaki, Ai; Takahashi, Yasuhiro; Tanabe, Mika; Hayashi, Ken; Imagawa, Yukihiro; Kaneda, Kazutoyo; Mimura, Masashi; Dai, Xiaoxian; Hayashida, Tomoko; Akamizu, Takashi

Immune tolerance induction using the thyrotropin receptor epitope 78-94 (p37) prevents Graves' disease in HLA-DR3 transgenic mice

利用促甲状腺激素受体表位78-94 (p37)诱导免疫耐受可预防HLA-DR3转基因小鼠发生格雷夫斯病。

Inaba, Hidefumi; Nonaka, Itsuki; Hashimoto, Daiki; Hirono, Moritoshi; Morita, Shuhei; Kimura, Hiroaki; Iwakura, Hiroshi; Akamizu, Takashi; Nakata, Masanori

Nodule-Specific NRF2-Targeted Upregulation in Patients With KEAP1 Mutations and Familial Nontoxic Multinodular Goiter

KEAP1 突变和家族性非毒性多结节性甲状腺肿患者中结节特异性 NRF2 靶向上调

Nishihara, Eijun; Fukata, Shuji; Hirokawa, Mitsuyoshi; Higuchi, Miyoko; Ito, Mitsuru; Nishikawa, Mitsushige; Miyauchi, Akira; Matsuse, Michiko; Mitsutake, Norisato; Ito, Yuka; Hishinuma, Akira; Kogai, Takahiko; Akamizu, Takashi

Proposal for including risk of malignancy and clinical management in the Japanese system for reporting thyroid cytopathology - A multi-institutional study

关于将恶性肿瘤风险和临床管理纳入日本甲状腺细胞病理学报告系统的提议——一项多中心研究

Hirokawa, Mitsuyoshi; Katoh, Ryohei; Amano, Takashi; Chiba, Tomohiro; Yamazaki, Naoko; Satoh, Shinya; Towata, Miyuki; Ohi, Yasuyo; Maeda, Yukari; Fukushima, Mitsuhiro; Sasaki, Eiji; Yasuoka, Hironao; Higuchi, Miyoko; Suzuki, Ayana; Akamizu, Takashi